» Articles » PMID: 24772447

The Cytotoxic Role of Intermittent High Glucose on Apoptosis and Cell Viability in Pancreatic Beta Cells

Overview
Journal J Diabetes Res
Publisher Wiley
Specialty Endocrinology
Date 2014 Apr 29
PMID 24772447
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Glucose fluctuations are both strong predictor of diabetic complications and crucial factor for beta cell damages. Here we investigated the effect of intermittent high glucose (IHG) on both cell apoptosis and proliferation activity in INS-1 cells and the potential mechanisms.

Methods: Cells were treated with normal glucose (5.5 mmol/L), constant high glucose (CHG) (25 mmol/L), and IHG (rotation per 24 h in 11.1 or 25 mmol/L) for 7 days. Reactive oxygen species (ROS), xanthine oxidase (XOD) level, apoptosis, cell viability, cell cycle, and expression of cyclinD1, p21, p27, and Skp2 were determined.

Results: We found that IHG induced more significant apoptosis than CHG and normal glucose; intracellular ROS and XOD levels were more markedly increased in cells exposed to IHG. Cells treated with IHG showed significant decreased cell viability and increased cell proportion in G0/G1 phase. Cell cycle related proteins such as cyclinD1 and Skp2 were decreased significantly, but expressions of p27 and p21 were increased markedly.

Conclusions: This study suggested that IHG plays a more toxic effect including both apoptosis-inducing and antiproliferative effects on INS-1 cells. Excessive activation of cellular stress and regulation of cyclins might be potential mechanism of impairment in INS-1 cells induced by IHG.

Citing Articles

The Emerging Role of p21 in Diabetes and Related Metabolic Disorders.

Elmitwalli O, Darwish R, Al-Jabery L, Algahiny A, Roy S, Butler A Int J Mol Sci. 2024; 25(23).

PMID: 39684919 PMC: 11641910. DOI: 10.3390/ijms252313209.


Metabolic, genetic and immunological features of relatives of type 1 diabetes patients with elevated insulin resistance.

Codazzi V, Salvatore V, Ragogna F, Marzinotto I, Anselmo A, Baldoni N J Endocrinol Invest. 2024; 48(3):765-775.

PMID: 39656436 PMC: 11876269. DOI: 10.1007/s40618-024-02497-x.


Association of xanthine oxidoreductase inhibitor use with insulin secretory capacity in patients with type 2 diabetes.

Kitamura A, Kurajoh M, Miki Y, Kakutani Y, Yamazaki Y, Ochi A J Diabetes Investig. 2024; 15(10):1500-1509.

PMID: 39078414 PMC: 11442858. DOI: 10.1111/jdi.14279.


MiR-17-5p Inhibits TXNIP/NLRP3 Inflammasome Pathway and Suppresses Pancreatic β-Cell Pyroptosis in Diabetic Mice.

Liu S, Tang G, Duan F, Zeng C, Gong J, Chen Y Front Cardiovasc Med. 2021; 8:768029.

PMID: 34881312 PMC: 8645844. DOI: 10.3389/fcvm.2021.768029.


Glucose Variability: How Does It Work?.

Klimontov V, Saik O, Korbut A Int J Mol Sci. 2021; 22(15).

PMID: 34360550 PMC: 8346105. DOI: 10.3390/ijms22157783.


References
1.
Kohnert K, Freyse E, Salzsieder E . Glycaemic variability and pancreatic β-cell dysfunction. Curr Diabetes Rev. 2012; 8(5):345-54. DOI: 10.2174/157339912802083513. View

2.
Li H, Telemaque S, Miller R, Marsh J . High glucose inhibits apoptosis induced by serum deprivation in vascular smooth muscle cells via upregulation of Bcl-2 and Bcl-xl. Diabetes. 2005; 54(2):540-5. DOI: 10.2337/diabetes.54.2.540. View

3.
Cozar-Castellano I, Takane K, Bottino R, Balamurugan A, Stewart A . Induction of beta-cell proliferation and retinoblastoma protein phosphorylation in rat and human islets using adenovirus-mediated transfer of cyclin-dependent kinase-4 and cyclin D1. Diabetes. 2003; 53(1):149-59. DOI: 10.2337/diabetes.53.1.149. View

4.
Hou Z, Li H, Gao L, Pan L, Zhao J, Li G . Involvement of chronic stresses in rat islet and INS-1 cell glucotoxicity induced by intermittent high glucose. Mol Cell Endocrinol. 2008; 291(1-2):71-8. DOI: 10.1016/j.mce.2008.03.004. View

5.
. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352(9131):837-53. View